Trials / Completed
CompletedNCT00892749
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
A Phase 3, Long-term Study in Patients With Chronic Kidney Disease (CKD) and Hyperphosphatemia on Hemodialysis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 248 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 for long-term dosing in chronic kidney disease and hyperphosphatemia patients on hemodialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1585 | oral |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2009-05-04
- Last updated
- 2015-05-04
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00892749. Inclusion in this directory is not an endorsement.